0000950170-24-042372.txt : 20240405
0000950170-24-042372.hdr.sgml : 20240405
20240405185809
ACCESSION NUMBER: 0000950170-24-042372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240404
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Hanjoon Alex
CENTRAL INDEX KEY: 0001919209
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34180
FILM NUMBER: 24827788
MAIL ADDRESS:
STREET 1: C/O FLUIDIGM CORPORATION
STREET 2: 2 TOWER PLACE, SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC.
CENTRAL INDEX KEY: 0001162194
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770513190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502666000
MAIL ADDRESS:
STREET 1: 2 TOWER PLACE
STREET 2: SUITE 2000
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLUIDIGM CORP
DATE OF NAME CHANGE: 20011113
4
1
ownership.xml
4
X0508
4
2024-04-04
0001162194
STANDARD BIOTOOLS INC.
LAB
0001919209
Kim Hanjoon Alex
C/O STANDARD BIOTOOLS INC.
2 TOWER PLACE, STE 2000
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Operating Officer
false
Common Stock
2024-04-04
4
M
false
70183
0
A
140366
D
Common Stock
2024-04-05
4
A
false
70702
0
A
211068
D
Restricted Stock Units
2024-04-04
4
M
false
70183
0
D
Common Stock
70183
140366
D
On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024.
Each RSU represents the contingent right to receive one share of the Issuer's common stock.
On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.
/s/ Hanjoon Alex Kim by Agnieszka Gallagher, Attorney-in-Fact
2024-04-05